Raptor Pharmaceutical Corp (NASDAQ:RPTP)

10.77
Delayed Data
As of Mar 05
 +0.47 / +4.56%
Today’s Change
7.12
Today|||52-Week Range
16.93
+2.38%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$712.2M

Company Description

Raptor Pharmaceutical Corp. is a biopharmaceutical company, which focuses on developing and commercializing life-altering therapeutics that treat debilitating and often fatal diseases. It has active development programs in cystinosis, a rare genetic disease, as well as other genetic and metabolic disorders. Raptor Pharmaceutical Corp was founded on September 29, 2009 and is headquartered in Novato, CA.

Contact Information

Raptor Pharmaceutical Corp.
5 Hamilton Landing
Novato California 94949
P:(415) 408-6200
Investor Relations:

Employees

Shareholders

Other institutional35.55%
Individual stakeholders28.10%
Mutual fund holders19.87%

Top Executives

Julie Anne SmithPresident, CEO, COO, Director & Executive VP
Michael P. SmithChief Financial & Accounting Officer
Todd C. ZankelChief Scientific Officer
Krishna R. PoluChief Medical Officer
Françoise De CraeckerSenior Vice President & GM-European Operations

To view my watchlist

Not a member yet?

Sign up now for a free account